As the world’s largest biotechnology event, the BIO International Convention provides several specialized opportunities geared towards start-up and emerging companies. The Start-Up Stadium was designed to provide start-up companies with the opportunity to engage key members of the investment community, venture philanthropy groups, and BIO attendees. This area in the BIO Exhibition provides an exciting and interactive experience where investors provide live feedback and judge 6 minute pitches presented by start-up biotech companies.
Janice Bourque, Hercules Technology Growth Capital
Ashok Chander, Cellanyx
Rajeev Dadoo, SR One
Alex de Winter, GE Ventures
David Donabedian, Axial Bio Therapeutics
Stephen Knight, F-Prime Capital
Jacqueline Lender, Mayor's Office of Boston
Andrew Meadow, Excelyrate Capital
Geoff Meyerson, Locust Walk
Walter Olesiak, Remiges Ventures
Kush Parmar, 5AM Ventures
Debbie Poenisch, VWR International
Joshua Resnick, SV Life Sciences
William Whelan, Mintz Levin Cohn Ferris Glovsky and Popeo PC
*Sub-committee will be updated periodically.
Thank You to Our 2017 Start-Up Stadium Sponsors!
BIO had 40 finalists for its third annual Start-Up Stadium event, taking place at the BIO International Convention from June 19th-22nd in San Diego, CA. In 2017, applications were submitted from coast to coast across the United States and countries around the world. The finalists, whose sole purpose is to develop cutting-edge technologies and therapeutic solutions while becoming commercially viable, span 14 U.S. states and the globe – with representation from biotech and pharma hotbed countries such as Canada, Germany, and India.
Applications were judged by experts with entrepreneurial, investment, start-up, economic development, capital formation, and academic backgrounds from both the public and private sectors. The first panel of judges reviewed over 100 applications in order to establish the current pool of 40+ highly-qualified finalists. The second panel will be evaluating the finalists’ during live presentations at the BIO International Convention.